.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Covington
Daiichi Sankyo
Cipla
Mallinckrodt
Baxter
AstraZeneca
Merck
Cerilliant
Novartis

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062512

« Back to Dashboard
NDA 062512 describes NYSTATIN, which is a drug marketed by Watson Labs, Teva, Mayne Pharma Inc, Quantum Pharmics, Wockhardt, Paddock Llc, Vintage, Odyssey Pharms, Fougera Pharms Inc, Pharmaderm, Nesher Pharms, Pharm Assoc, Taro, Vistapharm, Fougera Pharms, Usl Pharma, Perrigo New York, Allied Pharma Inc, Morton Grove, Gavis Pharms, Lyne, Sun Pharm Inds, Actavis Mid Atlantic, Pharmafair, Hi Tech Pharma, Vintage Pharms, G And W Labs Inc, Fougera, Sandoz, Alpharma Us Pharms, Heritage Pharms Inc, X Gen Pharms, Taro Pharm, Upsher-smith Labs, Glenmark Pharms Ltd, Akorn, Dr Reddys Labs Ltd, Perrigo Uk Finco, Riconpharma Llc, and Teligent Pharma Inc, and is included in sixty-nine NDAs. It is available from forty-nine suppliers. Additional details are available on the NYSTATIN profile page.

The generic ingredient in NYSTATIN is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.

Summary for NDA: 062512

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Pharmacology for NDA: 062512

Ingredient-typePolyenes

Suppliers and Packaging for NDA: 062512

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NYSTATIN
nystatin
SUSPENSION;ORAL 062512 ANDA Pharmaceutical Associates, Inc. 0121-4785 0121-4785-05 4 TRAY in 1 CASE (0121-4785-05) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE
NYSTATIN
nystatin
SUSPENSION;ORAL 062512 ANDA Pharmaceutical Associates, Inc. 0121-4785 0121-4785-35 10 TRAY in 1 CASE (0121-4785-35) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength100,000 UNITS/ML
Approval Date:Oct 29, 1984TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Colorcon
Johnson and Johnson
Cantor Fitzgerald
Covington
Chubb
Fuji
McKinsey
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot